Clinical Trials Browser

Phase 1/2 × Camurati-Engelmann Syndrome × pembrolizumab × Clear all

Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Camurati-Engelmann Syndrome, Carcinoma, Hepatocellular